Subcutaneous pythiosis in human treated successfully with antimicrobial treatment, debridement and immunotherapy

Moni Roy1, Joel Borden2, Douglas J Kasper3

  • 1Department of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA moniroy27@gmail.com.

BMJ Case Reports
|March 18, 2024
PubMed

Insights

Subcutaneous pythiosis, a rare human infection caused by Pythium insidiosum, requires novel treatment approaches. This case highlights successful immunotherapy combined with surgery and antimicrobials for a lower extremity infection.

Area of Science:

  • Medical Mycology
  • Infectious Diseases

Background:

  • Pythiosis is a rare infection caused by the oomycete Pythium insidiosum, primarily affecting animals.
  • Human cases of subcutaneous pythiosis are exceptionally uncommon, lacking established treatment protocols.

Observation:

  • A young man presented with non-healing lower extremity ulcers after swamp water exposure.
  • Initial antibiotic treatments were ineffective, necessitating further investigation.

Findings:

  • Deep wound culture and Polymerase Chain Reaction (PCR) confirmed Pythium insidiosum infection.
  • A multidisciplinary approach involving infectious disease and veterinary specialists was crucial.

Implications:

  • This case demonstrates the successful use of immunotherapy alongside surgical debridement and antimicrobials for human pythiosis.
  • It underscores the importance of considering rare pathogens and exploring novel therapeutic strategies in complex infections.